The use of high dose methotrexate (MTX) in the management of solid and haematological malignancies is currently under investigation in a number of clinical trials. Citrovorum rescue (CVR) is an essential part of such therapy. Given at an interval after MTX folinic acid reverses the cytotoxic effect and prevents the otherwise inevitable bone marrow and intestinal toxicity caused by prolonged high serum MTX concentrations (Djerassi, 1975) . In recent protocols CVR is given 6-8 hourly commencing 24 h after MTX (UK Childrens Cancer Study Group, 1977, unpublished) . At least the first dose is given intravenously to ensure adequate blood levels and subsequent doses are given either orally or intramuscularly. Although some protocols do not involve parenteral CVR there has been a general reluctance to rely on oral administration even in the absence of clear contraindications such as vomiting or intolerance. One reason for this reluctance is the possibility that the acute toxic effect of MTX on the small gut might impair folate absorption and reduce the efficacy of rescue. The most severe structural and functional abnormalities in the small gut are evident 2-4 days after MTX and are usually associated with villos atrophy. Although such abnormalities are prevented by CVR early acute changes in enterocyte morphology and metabolism have been described within 6 h of drug administration. (Vitale et al., 1954; Trier, 1962) . Such abnormalities could impair absorption and make oral CVR inadvisable. To test this hypothesis small intestinal absorption was studied in the rat after high dose MTX. Direct estimation of folinic acid absorption was not possible due to the nonavailability of a suitable isotope-labelled preparation. Folic acid has, however, been shown to share the absorption mechanism (Rosenberg, 1975) and this structural analogue was used instead.
Male Wistar rats weighing 250-300 g were fasted for 16 h prior to study; water was freely available. volume of i.v. saline. At either 4 or 24 h after injection the animals were anaesthetised and a segment of proximal jejunum isolated and perfused using the continuous perfusion technique (Sladen & Harries, 1972) . A perfusion rate of 0.2 ml min-was used and the effluent collected over 3 consecutive 20 min periods after a 50 min equilibration period. The perfusate contained NaCl (145mM 1-i) KCI (4mM 1-'), NaHCO3 (25mM l-), polyethylene glycol (PEG 4000) 3gl-with 40uCi [i4C] PEG (Radiochemical Centre, Amsterdam) and folic acid 0.44mgl-i (10-6M) with l5YCi [3H] folic acid. pH was adjusted to 7 with CO2 and the osmolality of the solution was 290 mosm kg-'.
The initial perfusate solution and the effluent were analysed for sodium by flame photometry and glucose by colorimetric assay; [i4C] and [3H] concentrations were measured in 200 p aliquots in RIA Luma scintillant (LKB) using an LKB Wallac scintillation counter. Absorption rates (per g wet tissue weight) of water, sodium, glucose and folic acid were calculated using PEG as a nonabsorbable marker (Sladen & Dawson, 1969 respectively) did not differ significantly from salineinjected controls (0.27 + 0.04 M g-min-). Electron microscopic studies of jejunal mucosa from adults with psoriasis reveal patchy enterocyte vacuolation within 6 h of 2mg kg-' i.v. MTX (Trier, 1962) . Similar ultrastructural changes were seen in children with acute leukaemia after oral MTX (15mgm-2) (Gwavava et al., 1981) . These abnormalities are unrelated to the primary action of MTX which affects the rapidly-dividing crypt cell population and are probably due to the action of the drug on protein and RNA synthesis-a consequence of impaired one carbon transfer. ( Delmonte & Jukes, 1962) The functional effects of toxicity could be responsible for such MTX-induced methotrexate enterotoxicity have been widely malabsorption. A local toxic effect on villos cells studied in the experimental animal (Shaw et al., might be a consequence of the high biliary 1979, Capel et al., 1979 , Taminiau et al., 1980 but concentrations of MTX after high dose therapy absorption has been measured when there was (Halsted, 1972) . MTX also lowers intestinal mucosal severe villos atrophy and dysfunction was pH and impairs folate uptake (Lei et al., 1977 ) and therefore to be expected. The present study was luminal MTX could compete with folate at the site designed to determine whether high dose MTX of active transport (Selhub et al., 1973) . The present influenced absorptive function in the absence of study, however, demonstrates that despite these villos atrophy and, in particular, whether folate possibilities high dose MTX does not impair folic absorption was impaired.
acid absorption and is therefore unlikely to Two mechanisms are involved in folate absorption influence the absorption of the reduced form of (Rosenberg, 1976 ). An energy-dependent, structurefolinic acid which shares the same mechanisms of specific, saturable system which is shared by absorption. Moreover at 24h after MTX there was unreduced, reduced and substituted monoglutamyl an increase in the absorption of water, sodium and folates and a second passive mechanism that follows folic acid. (Taminiau, 1980) and pre-bone marrow transplant chemotherapy also increased intestinal permeability (Gomes et al., 1982) . It has been postulated that such changes are due to damage to mucosal junctional complexes and an increase in the villos tip extrusion zone (Pearson et al., 1982) . It is possible that the dilated intercellular spaces that were described after low dose MTX were due to increased water entry by this paracellular pathway (Guavava et al., 1981) . The enhanced absorption of folic acid may be a secondary phenomenon due to increased water and sodium uptake which overcomes any inhibitory effect that MTX might have upon active folate transport. An alternative explanation is that MTX occupies intracellular binding sites for folates thus reducing intracellular persistence of folic acid and increasing the rate of transmucosal passage. MTX has been shown to reduce mucosal concentrations of folic acid and enhance serosal to mucosal transport in everted sacs of rat jejunum (Selhub et al., 1973 ). In conclusion it seems likely that after high dose parenteral MTX the absorption of folinic acid is at least as good as in untreated cases and that oral CVR is unlikely to be impaired. 
